Insider Trading & Ownership - Gano Kyle

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gano Kyle
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-13
Sale
2024-02-15
5:40 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
1,352$132.89$179,674189,190
(Direct)
View
2024-02-06
Sale
2024-02-08
7:17 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
2,580$139.16$359,041133,952
(Direct)
View
2024-01-31
Sale
2024-02-02
7:17 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
1,541$140.7$216,813131,635
(Direct)
View
2024-01-02
Sale
2024-01-04
6:32 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
75,000$131.47$9,860,194130,250
(Direct)
View
2023-08-21
Sale
2023-08-23
8:05 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
2,132$107.41$228,993130,250
(Direct)
View
2023-02-06
Sale
2023-02-08
7:25 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
17,004$102.79$1,747,920128,096
(Direct)
View
2023-01-31
Sale
2023-02-02
5:15 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
1,541$109.98$169,486112,820
(Direct)
View
2022-02-07
Sale
2022-02-09
6:58 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
6,880$80.61$554,628111,173
(Direct)
View
2022-01-05
Sale
2022-01-07
6:04 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
28,266$85.5$2,416,751104,984
(Direct)
View
2021-02-05
Sale
2021-02-09
9:42 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
6,370$115.65$736,702156,839
(Direct)
View
2020-11-12
Sale
2020-11-16
6:11 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
2,257$90.73$204,77098,028
(Direct)
View
2020-08-05
Sale
2020-08-07
7:24 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
2,257$118.87$268,28695,997
(Direct)
View
2020-04-24
Sale
2020-04-28
8:40 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
1,934$99.47$192,37793,967
(Direct)
View
2020-02-07
Sale
2020-02-11
7:13 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
1,623$103.33$167,71091,975
(Direct)
View
2020-02-05
Sale
2020-02-07
6:54 pm
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
4,690$102.7$481,675179,345
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-01
Option Award
2024-11-01
7:52 pm
N/A
N/A
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Executive Officer
15,799$015,799
(Direct)
View
2024-02-13
Option Award
2024-02-15
5:40 pm
N/A
2034-02-13
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
54,024$0189,190
(Direct)
View
2024-01-02
Exercise
2024-01-04
6:32 pm
N/A
2024-01-16
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
75,000$19.59130,250
(Direct)
View
2023-02-13
Option Award
2023-02-15
7:10 pm
N/A
2033-02-13
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
74,053$074,053
(Direct)
View
2022-01-31
Option Award
2022-02-02
8:02 pm
N/A
2032-01-31
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
91,426$091,426
(Direct)
View
2022-01-05
Exercise
2022-01-07
6:04 pm
N/A
2022-01-12
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
28,266$8.66104,984
(Direct)
View
2021-02-08
Option Award(A)
2021-03-29
06:15 am
N/A
2031-02-08
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
49,049$049,049
(Direct)
View
2021-02-08
Option Award
2021-02-09
9:42 pm
N/A
2031-02-08
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
52,071$0156,839
(Direct)
View
2020-02-06
Option Award
2020-02-07
6:54 pm
N/A
2030-02-06
NEUROCRINE BIOSCIENCES INCNBIXGano Kyle
Chief Business Development Off
88,831$0179,345
(Direct)
View
(A) Indicate amendment filing.